Here's Why Moderna Doesn't Need IP Protection for Its COVID-19 Vaccine
In May, the Biden administration announced that it supported waiving all patent protections for COVID-19 vaccines in the negotiations at the World Trade Organization (WTO). If all 164 signatories to the World Trade Organization agree with this position, there will be no patent protections for COVID-19 vaccines. That would mean that any drug company could start offering generic versions of the vaccines.
At least one company, Moderna (NASDAQ: MRNA), is not at all concerned. In fact, Moderna already waived its own property rights to its COVID-19 vaccine during the pandemic last year. In this Fool Live clip, recorded on May 14, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Taylor Carmichael discuss why the WTO's patent negotiations aren't very relevant to Moderna.
Source Fool.com
